Given its low valuation and the seeming overreaction in the markets to the recent trial results, this is a stock that could ...

Eli Lilly's stock has been a strong winner over the past few years, powered by its portfolio of glucagon-like peptide-1 ...

This time last year, people were still bickering about whether Novo Nordisk's Wegovy and Eli Lilly & Co.'s Zepbound represented a shortcut to losing weight or a medical breakthrough. But with reams of ...

Smallcase revenue British biopharmaceutical company Juvenescence completes $100 million Series B financing Two types of chronic disease patients welcome good news! The state issued a document to ...

INR:9310. danske spil oddset regler 『Pharmaceutical Headlines』CD147 antibody clinical trial data released, epidemic makes disinfectant popular Chine ...

Tmall's shopping list for the pharmaceutical platform on Double Eleven! The transaction volume exceeded 100 million in just 2 minutes ...

INR:0330. ace 2 three plus 4 Novo Nordisk's Fiasp is approved in Canada for use in pediatric patients aged ≥ 2 years! After much anticipation, this new breas ...

live cricket score india and australia Innovent Biologics Obtains Exclusive Rights to Two Cell Immunotherapy Products in Mainland China, Hong Kong and Macau Novo Nordisk Q1 2020: China grew 13%, ...

Eli Lilly (LLY) emerges among the top performers in Big Pharma in 2024 with obesity drug success, while Novo Nordisk (NVO) ...